메뉴 건너뛰기




Volumn 41, Issue 2, 2012, Pages 712-720

Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma

Author keywords

AZD6244; Combination therapy; RCC xenograft; Renal cell carcinoma; Sorafenib

Indexed keywords

BIM PROTEIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; P70S6K PROTEIN; P90RSK PROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN; PROTEIN BAD; PROTEIN P27; SELUMETINIB; SORAFENIB; SURVIVIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

EID: 84863561186     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1494     Document Type: Article
Times cited : (25)

References (14)
  • 1
    • 0036895290 scopus 로고    scopus 로고
    • Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma
    • DOI 10.1200/JCO.2002.05.111
    • Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA and Belldegrun AS: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20: 4559-4566, 2002. (Pubitemid 35402959)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.23 , pp. 4559-4566
    • Zisman, A.1    Pantuck, A.J.2    Wieder, J.3    Chao, D.H.4    Dorey, F.5    Said, J.W.6    DeKernion, J.B.7    Figlin, R.A.8    Belldegrun, A.S.9
  • 4
    • 60849120120 scopus 로고    scopus 로고
    • A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer
    • Heng DY, Chi KN, Murray N, Jin T, Garcia JA, Bukowski RM, Rini BI and Kollmannsberger C: A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer. Cancer 115: 776-783, 2009.
    • (2009) Cancer , vol.115 , pp. 776-783
    • Heng, D.Y.1    Chi, K.N.2    Murray, N.3    Jin, T.4    Garcia, J.A.5    Bukowski, R.M.6    Rini, B.I.7    Kollmannsberger, C.8
  • 5
    • 68949145218 scopus 로고    scopus 로고
    • Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
    • Motzer RJ, Hutson TE, Tomczak P, et al: Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27: 3584-3590, 2009.
    • (2009) J Clin Oncol , vol.27 , pp. 3584-3590
    • Motzer, R.J.1    Hutson, T.E.2    Tomczak, P.3
  • 8
    • 68949199667 scopus 로고    scopus 로고
    • Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: Results from a multicenter study
    • Zhang H, Dong B, Lu JJ, Yao X, Zhang S, Dai B, Shen Y, Zhu Y, Ye D and Huang Y: Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter study. BMC Cancer 9: 249-256, 2009.
    • (2009) BMC Cancer , vol.9 , pp. 249-256
    • Zhang, H.1    Dong, B.2    Lu, J.J.3    Yao, X.4    Zhang, S.5    Dai, B.6    Shen, Y.7    Zhu, Y.8    Ye, D.9    Huang, Y.10
  • 9
    • 79952671531 scopus 로고    scopus 로고
    • Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
    • Yuen JS, Sim MY, Siml HG, Chong TW, Lau WK, Cheng CW and Huynh H: Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model. Br J Cancer 104: 941-947, 2011.
    • (2011) Br J Cancer , vol.104 , pp. 941-947
    • Yuen, J.S.1    Sim, M.Y.2    Siml, H.G.3    Chong, T.W.4    Lau, W.K.5    Cheng, C.W.6    Huynh, H.7
  • 10
    • 71349084002 scopus 로고    scopus 로고
    • AZD6244 enhances the antitumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
    • Huynh H, Ngo VC, Koong HN, et al: AZD6244 enhances the antitumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). J Hepat 52: 79-87, 2010.
    • (2010) J Hepat , vol.52 , pp. 79-87
    • Huynh, H.1    Ngo, V.C.2    Koong, H.N.3
  • 11
    • 33846812600 scopus 로고    scopus 로고
    • Xenografts of human hepatocellular carcinoma: A useful model for testing drugs
    • Huynh H, Soo KC, Chow PK, Panasci L and Tran E: Xenografts of human hepatocellular carcinoma: A useful model for testing drugs. Clin Cancer Res 12: 4306-4314, 2006.
    • (2006) Clin Cancer Res , vol.12 , pp. 4306-4314
    • Huynh, H.1    Soo, K.C.2    Chow, P.K.3    Panasci, L.4    Tran, E.5
  • 13
    • 77956084780 scopus 로고    scopus 로고
    • Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program
    • Bukowski RM, Stadler WM, McDermott DF, et al: Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program. Oncology 78: 340-347, 2010.
    • (2010) Oncology , vol.78 , pp. 340-347
    • Bukowski, R.M.1    Stadler, W.M.2    McDermott, D.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.